Keppra and Cresemba drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Cresemba (isavuconazonium sulfate). Common drug interactions include dizziness among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Cresemba. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

On Jul, 18, 2026

39 people who take Keppra and Cresemba together, and have interactions are studied.

What are the common drug interactions of Keppra and Cresemba, by gender? *:

female:

Dizziness
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)
Headache (pain in head)
Hyperglycaemia (high blood sugar)
Klebsiella infection
Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

male:

Pyrexia (fever)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
C-reactive protein increased
Chest pain
Electrocardiogram qt prolonged
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Gait disturbance
Headache (pain in head)

What are the common drug interactions of Keppra and Cresemba, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal pain
Cardiac arrest
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hyperkalaemia (damage to or disease of the kidney)
Polydipsia (excessive thirst)
Hyperglycaemia (high blood sugar)

10-19:

Hyperkalaemia (damage to or disease of the kidney)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Melaena (the passage of black, tarry stools)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Neutropenia (an abnormally low number of neutrophils)
Pericardial effusion (fluid around the heart)
Pulmonary haemorrhage (acute bleeding from the lung)

20-29:

Chloroma (green-coloured tumour)
Acute lymphocytic leukaemia (cancer of the white blood cells)
Acute myelomonocytic leukaemia (cancer of the blood-forming organs)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Depressed level of consciousness
Haematocrit decreased
Haemoglobin decreased
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)

30-39:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Death
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)

40-49:

Blood bilirubin increased
Confusional state
Creatinine renal clearance decreased
Delirium (wild excitement)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Eye swelling
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Mucosal inflammation (infection of mucous membrane)
Neutropenia (an abnormally low number of neutrophils)
Orbital oedema (swelling of orbit)

50-59:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Klebsiella infection

60+:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Gait disturbance
Haemoglobin decreased
Headache (pain in head)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hypotension (abnormally low blood pressure)
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Diabetes: 8 people, 20.51%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 8 people, 20.51%
Insomnia (sleeplessness): 8 people, 20.51%
Bacterial Infection: 8 people, 20.51%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 17.95%
Nausea (feeling of having an urge to vomit): 5 people, 12.82%
Indigestion: 5 people, 12.82%
Fever: 5 people, 12.82%
Pain: 5 people, 12.82%
Constipation: 5 people, 12.82%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Cresemba?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously